Leap Therapeutics Inc. buy Raymond James
Start price
14.11.23
/
50%
€1.37
Target price
14.11.24
€16.21
Performance (%)
59.12%
Price
25.09.24
€2.36
Summary
This prediction is currently active. With a performance of 59.12% the BUY prediction by Raymond_James is a big success. This prediction currently runs until 14.11.24. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Leap Therapeutics Inc. | - | - |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by Raymond_James for this prediction
In the thread Leap Therapeutics Inc diskutieren
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target lowered by analysts at Raymond James from $18.50 to $17.50. They now have an "outperform" rating on the stock.
Ratings data for LPTX provided by MarketBeat